The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.
 
Danika Scott
No Relationships to Disclose
 
Kerry Kingham
No Relationships to Disclose
 
Rachel Hodan
No Relationships to Disclose
 
Cindy Ma
No Relationships to Disclose
 
Meredith Mills
No Relationships to Disclose
 
James M. Ford
Research Funding - AstraZeneca (Inst); Genentech (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
 
Allison W. Kurian
Research Funding - Myriad Genetics (Inst)
Other Relationship - Ambry Genetics; Color Genomics; GeneDx/BioReference; Genentech; InVitae
 
Melinda L. Telli
Consulting or Advisory Role - Abbvie; Aduro Biotech; Celgene; Daiichi Sankyo; G1 Therapeutics; Genentech/Roche; Immunomedics; Lilly; Merck
Research Funding - Abbvie (Inst); Bayer (Inst); Biothera (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics; Pfizer (I)